Araújo R, Ramalhete L, Paz H et al (2021) A new method to predict genotoxic effects based on serum molecular profile. Spectrochim Acta A Mol Biomol Spectrosc 255:119680. https://doi.org/10.1016/j.saa.2021.119680
Article CAS PubMed Google Scholar
Aristizabal-Pachon AF, Castillo WO (2020) Genotoxic evaluation of occupational exposure to antineoplastic drugs. Toxicol Res 36:29–36. https://doi.org/10.1007/s43188-019-00003-7
Article CAS PubMed Google Scholar
Berdasco M, Esteller M (2010) Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell 19:698–711. https://doi.org/10.1016/j.devcel.2010.10.005
Article CAS PubMed Google Scholar
Bouraoui S, Brahem A, Tabka F et al (2011) Assessment of chromosomal aberrations, micronuclei and proliferation rate index in peripheral lymphocytes from Tunisian nurses handling cytotoxic drugs. Environ Toxicol Pharmacol 31:250–257. https://doi.org/10.1016/j.etap.2010.11.004
Article CAS PubMed Google Scholar
Brumen V, Horvat D (1996) Work environment influence on cytostatics-induced genotoxicity in oncologic nurses. Am J Ind Med 30:67–71. https://doi.org/10.1002/(SICI)1097-0274(199607)30:1%3c67::AID-AJIM11%3e3.0.CO;2-6
Article CAS PubMed Google Scholar
Burgaz S, Karahalıl B, Bayrak P et al (1999) Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics. Mutat Res Genetic Toxicol Environ Mutagen 439:97–104. https://doi.org/10.1016/S1383-5718(98)00180-6
Burgaz S, Karahalil B, Canli Z et al (2002) Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations. Hum Exp Toxicol 21:129–135. https://doi.org/10.1191/0960327102ht230oa
Article CAS PubMed Google Scholar
Cavallo D, Ursini CL, Perniconi B et al (2005) Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutat Res Genetic Toxicol Environ Mutagen 587:45–51. https://doi.org/10.1016/j.mrgentox.2005.07.008
Cavallo D, Ursini CL, Omodeo-Salè E, Iavicoli S (2007) Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses administering antineoplastic drugs. Mutat Res Genetic Toxicol Environ Mutagen 628:11–18. https://doi.org/10.1016/j.mrgentox.2006.10.014
Cavallo D, Ursini CL, Rondinone B, Iavicoli S (2009) Evaluation of a suitable DNA damage biomarker for human biomonitoring of exposed workers. Environ Mol Mutagen 50:781–790. https://doi.org/10.1002/em.20501
Article CAS PubMed Google Scholar
Choudhuri S, Kaur T, Jain S et al (2021) A review on genotoxicity in connection to infertility and cancer. Chem Biol Interact 345:109531. https://doi.org/10.1016/j.cbi.2021.109531
Article CAS PubMed Google Scholar
Connor T, McLauchlan R, Vandenbroucke J (2007) Preface. J Oncol Pharm Pract 13:1–2. https://doi.org/10.1177/1078155207082350
Connor TH, DeBord DG, Pretty JR et al (2010) Evaluation of antineoplastic drug exposure of health care workers at three university-based US Cancer centers. J Occup Environ Med 52:1019–1027. https://doi.org/10.1097/JOM.0b013e3181f72b63
Cornetta T, Padua L, Testa A et al (2008) Molecular biomonitoring of a population of nurses handling antineoplastic drugs. Mutat Res Genetic Toxicol Environ Mutagen 638:75–82. https://doi.org/10.1016/j.mrfmmm.2007.08.017
Crul M, Hilhorst S, Breukels O et al (2020) Occupational exposure of pharmacy technicians and cleaning staff to cytotoxic drugs in Dutch hospitals. J Occup Environ Hyg 17:343–352. https://doi.org/10.1080/15459624.2020.1776299
Article CAS PubMed Google Scholar
De Carvalho DD, Sharma S, You JS et al (2012) DNA methylation screening identifies driver epigenetic events of cancer cell survival. Cancer Cell 21:655–667. https://doi.org/10.1016/j.ccr.2012.03.045
Article CAS PubMed PubMed Central Google Scholar
de Jonge ME, Huitema ADR, Rodenhuis S, Beijnen JH (2005) Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 44:1135–1164. https://doi.org/10.2165/00003088-200544110-00003
El-Ebiary AA, Abuelfadl AA, Sarhan NI (2013) Evaluation of genotoxicity induced by exposure to antineoplastic drugs in lymphocytes of oncology nurses and pharmacists. J Appl Toxicol 33:196–201. https://doi.org/10.1002/jat.1735
Article CAS PubMed Google Scholar
Fakher HM, Metwally ES, El-Shafey RSH (2020) The potential genotoxic effects of antineoplastic drugs in occupationally exposed nurses. Asia Pac J Med Toxicol 9(2):60–66. https://doi.org/10.22038/apjmt.2020.16388
Farmer PB, Sepai O, Lawrence R et al (1996) Biomonitoring human exposure to environmental carcinogenic chemicals. Mutagenesis 11:363–381. https://doi.org/10.1093/mutage/11.4.363
Article CAS PubMed Google Scholar
Friedman B, Cronstein B (2019) Methotrexate mechanism in treatment of rheumatoid arthritis. Jt Bone Spine 86:301–307. https://doi.org/10.1016/j.jbspin.2018.07.004
Fuchs J, Hengstler JG, Jung D et al (1995) DNA damage in nurses handling antineoplastic agents. Mutat Res Genet Toxicol 342:17–23. https://doi.org/10.1016/0165-1218(95)90086-1
Fucic A, Jazbec A, Mijic A et al (1998) Cytogenetic consequences after occupational exposure to antineoplastic drugs. Mutat Res Genetic Toxicol Environ Mutagen 416:59–66. https://doi.org/10.1016/S1383-5718(98)00084-9
Graeve CU, McGovern PM, Alexander B et al (2017) Occupational exposure to antineoplastic agents. Workplace Health Saf 65:9–20. https://doi.org/10.1177/2165079916662660
Gulten T, Evke E, Ercan I et al (2011) Lack of genotoxicity in medical oncology nurses handling antineoplastic drugs: Effect of work environment and protective equipment. Work 39:485–489. https://doi.org/10.3233/WOR-2011-1198
Hall AL, Davies HW, Demers PA et al (2013) Occupational exposures to antineoplastic drugs and ionizing radiation in Canadian veterinary settings: findings from a National Surveillance Project. Can J Public Health 104:e460–e465. https://doi.org/10.17269/cjph.104.4167
Article PubMed PubMed Central Google Scholar
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674. https://doi.org/10.1016/j.cell.2011.02.013
Article CAS PubMed Google Scholar
Hedmer M, Wohlfart G (2012) Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals. J Environ Monit 14:1968. https://doi.org/10.1039/c2em10704j
Article CAS PubMed Google Scholar
Hessel H, Radon K, Pethran A et al (2001) The genotoxic risk of hospital, pharmacy and medical personnel occupationally exposed to cytostatic drugs—evaluation by the micronucleus assay. Mutat Res Genetic Toxicol Environ Mutagen 497:101–109. https://doi.org/10.1016/S1383-5718(01)00236-4
Hongping D, Zhang M, He J et al (2005) Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic end-points. Mutagenesis 20:351–357. https://doi.org/10.1093/mutage/gei048
Hongping D, Jianlin L, Meibian Z et al (2006) Detecting the cytogenetic effects in workers occupationally exposed to vincristine with four genetic tests. Mutat Res Genetic Toxicol Environ Mutagen 599:152–159. https://doi.org/10.1016/j.mrfmmm.2006.02.003
Huang YW, Jian L, Zhang MB et al (2012) An investigation of oxidative dna damage in pharmacy technicians exposed to antineoplastic drugs in two Chinese hospitals using the urinary 8-OHdG assay. Biomed Environ Sci 25:109–116. https://doi.org/10.3967/0895-3988.2012.01.016
Article CAS PubMed Google Scholar
Huang X, Gao C, Cai W et al (2022) Effect of occupational exposure to antineoplastic drugs on DNA damage in nurses: a cross-sectional study. Occup Environ Med 79:253–258. https://doi.org/10.1136/oemed-2021-107913
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer (1987) Overall evaluations of carcinogenicity: an updating of IARC monographs, volumes 1 to 42. International Agency for Research on Cancer
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer (1990) Pharmaceutical drugs. IARC
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer (2000) Some antiviral and antineoplastic drugs, and other pharmaceutical agents. IARC
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer (2012) Monographs on the evaluation of carcinogenic risks to humans
Izdes S, Sardas S, Kadioglu E et al (2009) Assessment of genotoxic damage in nurses occupationally exposed to anaesthetic gases or antineoplastic drugs by the comet assay. J Occup Health 51:283–286. https://doi.org/10.1539/joh.M8012
Jakab MG, Major J, Tompa A (2001) Follow-up genotoxicological monitoring of nurses handling antineoplastic drugs. J Toxicol Environ Health A 62:307–318. https://doi.org/10.1080/152873901300018011
Article CAS PubMed Google Scholar
Jiang H, Panda S, Gekara NO (2019) Comet and micronucleus assays for analyzing DNA damage and genome integrity. Methods Enzymol 625:299–307. https://doi.org/10.1016/bs.mie.2019.05.015
Article CAS PubMed Google Scholar
Kašuba V, Rozgaj R, Garaj-Vrhovac V (1999) Analysis of sister chromatid exchange and micronuclei in peripheral blood lymphocytes of nurses handling cytostatic drugs. J Appl Toxicol 19:401–404. https://doi.org/10.1002/(SICI)1099-1263(199911/12)19:6%3c401::AID-JAT592%3e3.0.CO;2-H
留言 (0)